[Multidisciplinary treatment of lung cancer]

In our hospital 94 patients with small cell lung cancer were admitted the past 10 years. 21 patient have undergone surgical resection following the chemotherapy with VEMT regimen. The 5 year survival rate of the patients after resection was 32.7%. The MST for 52 non-surgical patient received VEMT regimen was 8 M, but MST for the recent 15 patients received CAV or COMP regimens is prolonged by 17 M. On the treatment for non-small cell lung cancer, our recent study shows a significant improvement in response rates for patients on platinum-containing combination chemotherapy. CAP regimen produces a longer MST in patients with adenocarcinoma or large cell carcinoma compared with MFC regimen (13 M vs 9 M).